Fanny E. Volat, et.al., Depressed levels of prostaglandin F2α in mice lacking Akr1b7 increase basal adiposity and predispose to diet-induced obesity., Diabetes, 2012, 61

http://rdf.ncbi.nlm.nih.gov/pubmed/22851578

Fanny E. Volat, et.al., Depressed levels of prostaglandin F2α in mice lacking Akr1b7 increase basal adiposity and predispose to diet-induced obesity., Diabetes, 2012, 61

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5568561

class

http://purl.org/net/cito/citesAsAuthority

• Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5568561

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal white adipose tissue physiology_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0005670I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• decreased food intake_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0011940I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased circulating insulin level_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0002079I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased circulating leptin level_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0005669I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased gonadal fat pad weight_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0009285I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased liver weight_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0002981I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased white adipose tissue amount_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0000008I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased susceptibility to diet-induced obesity_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0005658I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased inguinal fat pad weight_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0009292I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased white fat cell size_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0009118I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• decreased respiratory quotient_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0010379I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• insulin resistance_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0005331I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased body weight_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0001260I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased liver triglyceride level_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0009355I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• hepatic steatosis_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0002628I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased adiponectin level_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0004892I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased circulating triglyceride level_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0001552I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• increased circulating glycerol level_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0003443I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm
• decreased energy expenditure_Akr1b7<tm1.1Anm>/Akr1b7<tm1.1Anm>
  http://metadb.riken.jp/0004890I129Akr1b7tm11AnmAkr1b7tm11AnmAkr1b7tm11Anm